# Anterior Cruciate Ligament Pain Study

> **NCT02604550** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 115 (actual)

## Conditions studied

- Anterior Cruciate Ligament Reconstruction

## Interventions

- **DRUG:** Ropivacaine 0.5%
- **DRUG:** Percocet 7.5/325
- **DRUG:** Naprosyn 500 mg

## Key facts

- **NCT ID:** NCT02604550
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02604550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02604550, "Anterior Cruciate Ligament Pain Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02604550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*